Rat hepatic stellate cell expression of α2-macroglobulin is a feature of cellular activation:: implications for matrix remodelling in hepatic fibrosis
Rat hepatic stellate cell expression of α2-macroglobulin is a feature of cellular activation:: implications for matrix remodelling in hepatic fibrosis
复制标题
DOI:
10.1042/cs19980020
复制
发表时间:
1998-08-01
期刊:
影响因子:
6
通讯作者:
Arthur, MJP
中科院分区:
文献类型:
--
作者:
Kawser, CA;Iredale, JP;Arthur, MJP
1. Hepatic stellate cells are key mediators of hepatic fibrosis. We have studied hepatic stellate cell expression of the collagenase and general protease inhibitor alpha 2-macroglobulin after activation in tissue culture and in response to certain cytokines.2. Hepatic stellate cells isolated by Pronase-collagenase digestion were activated by culture on uncoated plastic. By Northern analysis hepatic stellate cells undergoing activation (5 days) expressed alpha 2-macroglobulin mRNA and alpha 2-macroglobulin could be immunolocalized to hepatic stellate cells from 5 to 15 days of culture.3. By ELISA of cell culture supernatants hepatic stellate cell secretion of alpha 2-macroglobulin was found to increase from 2.78 +/- 1.13 ng.ml(-1).mu g(-1) DNA per 24 h at 5 days of culture (n = 8) to 13.55 +/- 4.64 ng.ml(-1).mu g(-1) DNA per 24 h at 15 days of culture (n = 7). Stimulation of hepatic stellate cells with interleukin-6 at 5 days caused a significant increase in alpha 2-macroglobulin expression as did exposure to Kupffer-cell conditioned medium. However, exposure of hepatic stellate cells to interleukin-1, transforming growth factor-beta(1) and tumour necrosis factor-alpha had no significant effect.4. During profibrotic liver injury plasma alpha 2-macroglobulin levels were found to increase to between 850% and 250% of the control value (100%) after bile duct ligation (72 h to 13 days respectively), and to 1166% and 1106% of the control value during progressive CCl(4)-induced fibrosis (24 h to 4 weeks respectively).5. These data suggest that hepatic stellate cells are a potential source of the potent protease inhibitor alpha 2-macroglobulin, expression of which may inhibit matrix remodelling during progressive fibrosis.